Adenosine Pathway Clinical Trial Landscape Infographic
Our Beacon Checkpoint research team and the producers of the 2023 Adenosine-Targeted Cancer Immunotherapies Summit have carefully crafted this free infographic to provide you with a deep dive into the adenosine-pathway clinical trial landscape, using data from the Beacon Checkpoint database.
The data in this infographic reviews:
The number of adenosine-pathway targeted therapies entering the clinic since 2011.
Status and modalities of adenosine-pathway targeted therapies.
Clinical trials by phase over the years.
Top disease indications.
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
